⌘K
Loading ticker…
As of 2026-08-24, Chemed Corporation (CHE) has a 3-month relative strength percentile of 84 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.5%, relative volume 0.74×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CHE is in a stage 2 uptrend, week 4. Currently in a 11-day base; basing ADR 2.3% (broad 2.6%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 8.2% / 22.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CHE is held by 43 ETFs as of May 2026. Top owner: REGL at 1.79% weight, $30M notional. Top 3 carry $65M.
Held by 154 ETFs · $1.3B across latest filings · largest weight 3.40% (SCDV).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| REGL | 1.79% | $30M | +0.48 pp |
| VHTVanguard Health Care ETF | 0.10% | $18M | — |
| FNDA | 0.19% | $17M | +0.03 pp |
| OUSM | 1.88% | $16M | +0.09 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.11% | $16M | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.02% |
| $12M |
| — |
| IVOO | 0.17% | $10M | — |
| SCHXSchwab U.S. Large-Cap ETF | 0.01% | $6M | — |
| OMFL | 0.13% | $6M | +0.12 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $4M | — |
Showing 10 of 43 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CHE Jan avg: 1.56% median: 0.60% win: 50% σ: 3.17% n: 4 2022-04-12 → 2026-07-31 | CHE Feb avg: 2.94% median: 4.44% win: 75% σ: 4.88% n: 4 2022-04-12 → 2026-07-31 | CHE Mar avg: 0.04% median: 2.47% win: 75% σ: 5.28% n: 4 2022-04-12 → 2026-07-31 | CHE Apr avg: -0.94% median: -2.72% win: 40% σ: 9.06% n: 5 2022-04-12 → 2026-07-31 | CHE May avg: -1.56% median: -1.42% win: 20% σ: 1.33% n: 5 2022-04-12 → 2026-07-31 | CHE Jun avg: -1.96% median: -2.13% win: 40% σ: 8.89% n: 5 2022-04-12 → 2026-07-31 | CHE Jul avg: 0.55% median: 2.49% win: 60% σ: 11.00% n: 5 2022-04-12 → 2026-07-31 | CHE Aug avg: 2.75% median: 0.90% win: 50% σ: 5.91% n: 4 2022-04-12 → 2026-07-31 (current) | CHE Sep avg: -1.60% median: -0.31% win: 50% σ: 4.93% n: 4 2022-04-12 → 2026-07-31 | CHE Oct avg: 0.36% median: 1.64% win: 50% σ: 8.79% n: 4 2022-04-12 → 2026-07-31 | CHE Nov avg: 4.98% median: 3.89% win: 100% σ: 4.81% n: 4 2022-04-12 → 2026-07-31 | CHE Dec avg: -2.18% median: -2.21% win: 25% σ: 4.33% n: 4 2022-04-12 → 2026-07-31 |